- Filed
- Nov 13, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Nov 9, 2023 | 5.06B sh |
| Short Term Investments | Q1 2024 · Sep 30, 2023 | $5.01M |
| Cash And Equivalents | Q1 2024 · Sep 30, 2023 | $34.93M |
| Cash And Equivalents | Q1 2024 · Jun 30, 2023 | $37.19M |
| Current Liabilities | Q1 2024 · Sep 30, 2023 | $329.11K |
| Current Liabilities | Q1 2024 · Jun 30, 2023 | $340.25K |
| Total Liabilities | Q1 2024 · Sep 30, 2023 | $338.32K |
| Total Liabilities | Q1 2024 · Jun 30, 2023 | $376.98K |
| Current Assets | Q1 2024 · Sep 30, 2023 | $47.87M |
| Current Assets | Q1 2024 · Jun 30, 2023 | $48.03M |
| Total Assets | Q1 2024 · Sep 30, 2023 | $51.04M |
| Total Assets | Q1 2024 · Jun 30, 2023 | $51.21M |
| Shares Diluted | Q1 2024 · Sep 30, 2022 | 4.27B sh |
| Capex | Q1 2024 · Sep 30, 2022 | $33.81K |
| Operating Cash Flow | Q1 2024 · Sep 30, 2022 | −$281.54K |
| Stockholders Equity restated | Q1 2024 · Sep 30, 2022 | $22.84M |
| Stockholders Equity restated | Q1 2024 · Jun 30, 2022 | $23.74M |
| Eps Diluted | Q1 2024 · Sep 30, 2022 | $0.00 |
| Eps Basic | Q1 2024 · Sep 30, 2022 | $0.00 |
| Sga Expense | Q1 2024 · Sep 30, 2022 | $235.11K |
| Rd Expense | Q1 2024 · Sep 30, 2022 | $305.53K |
| Net Income | Q1 2024 · Sep 30, 2022 | −$896.95K |
| Operating Income | Q1 2024 · Sep 30, 2022 | −$638.7K |